Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors

Area of Science:

• Stem Cell Biology
• Regenerative Medicine
• Genetics

Background:

• Induced tissue-specific stem/progenitor (iTS/iTP) cells offer advantages over induced pluripotent stem (iPS) cells, including easier generation, higher differentiation efficiency, and no teratoma formation.
• Previous research has focused on iPS cells, but iTS/iTP cells present a promising alternative for specific therapeutic applications.

Purpose of the Study:

• To generate iTS cells from mouse pancreatic tissues (iTS-P cells) using two distinct reprogramming methods: OSKM (Oct3/4, Sox2, Klf4, c-Myc) and YAP (Yap1).
• To evaluate and compare the reprogramming efficiency and differentiation potential of iTS-P cells generated by these two methods.
• To assess the suitability of these iTS-P cells for differentiation into insulin-producing cells (IPCs).

Main Methods:

• Generation of iTS-P cells using plasmid vectors expressing either OSKM or YAP factors.
• Evaluation of reprogramming efficiency and characterization of iTS-P cell clones (iTS-P OSKM2 and iTS-P YAP9).
• Assessment of differentiation into IPCs and comparison with embryonic stem (ES) cells.
• Genomic bisulfite sequencing to analyze DNA methylation of pluripotency factors.
• Unsupervised hierarchical clustering of gene expression profiles.

Main Results:

• No significant difference in reprogramming efficiency was observed between the OSKM and YAP methods.
• Both iTS-P OSKM2 and iTS-P YAP9 cells exhibited high efficiency in differentiating into IPCs, surpassing ES cells.
• These iTS-P cells expressed endoderm and pancreatic progenitor markers.
• Partial methylation of Oct3/4 and Nanog was observed in both iTS-P cell types.
• Gene expression profiling indicated iTS-P YAP9 cells were closer to ES cells, though Oct3/4 and Nanog expression was lower in both iTS-P types compared to ES cells.

Conclusions:

• No substantial difference exists in the characteristics of iTS-P cells generated by OSKM or YAP induction.
• iTS-P cells demonstrate superior differentiation efficiency into IPCs compared to ES cells.
• These findings highlight the promising potential of iTS-P cells for clinical applications in diabetes treatment.